Criteria and recommendations for vitamin C intake

JAMA

Volumn 281, Issue 15, 1999, Pages 1415-1423

  Levine, Mark ^a,c   Rumsey, Steven C ^a   Daruwala, Rushad ^a   Park, Jae B ^b   Wang, Yaohui ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID;

ARTICLE; BIOAVAILABILITY; CANCER PREVENTION; DIETARY INTAKE; DOSE RESPONSE; FRUIT; HEMOLYSIS; HYPERURICOSURIA; IRON OVERLOAD; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEADY STATE; TREATMENT PLANNING; URINARY EXCRETION; VEGETABLE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 0033590959     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.15.1415     Document Type: Article

References (107)

1. Levine M. New concepts in the biology and biochemistry of ascorbic acid. W Engl J Med. 1986;314: 892-902.
2. Levine M, Rumsey SC, Wang V, et al. Vitamin C. In: Filer LJ, Ziegler EE, eds. Present Knowledge in Nutrition. Washington, DC: International Life Sciences Institute; 1996:146-159.
3. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol. 1997;10:485-494.
4. Levine M, Daruwala RC, Park JB, et al. Does vitamin C have a pro-oxidant effect? Nature. 1998;395: 231-232.
5. Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease. W Engl J Med. 1997; 337:408-416.
6. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 1990;82:185-191.
7. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C, and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol. 1995;11:97G-103G.
8. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
9. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
10. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke. Clin Invest Med. 1993;71:3-6.
11. Schorah CJ. Vitamin C and gastric cancer prevention. In: Paoletti R, Sies H. Bug J, Grossi E, Poli A, eds. Vitamin C: The State of The Art in Disease Prevention Sixty Years After the Nobel Prize. Milan, Italy: Springer; 1998:41-49.
12. Correa P. Human gastric carcinogenesis. Cancer Res. 1992;52:6735-6740.
13. Sobala GM, Schorah CJ, Pignatelli B, et al. High gastric juice ascorbic acid concentrations in members of a gastric cancer family. Carcinogenesis. 1993;14: 291-292.
14. Byers R, Guerrieri N. Epidemiologic evidence for vitamin C and vitamin E in cancer prevention. Am J Clin Nutr. 1995;62(suppl):1385S-1392S.
15. Hallberg L, Brune M, Rossander-Hulthen L. Is there a physiological role of vitamin C in iron absorption? Ann N Y Acad Sci. 1987;498:324-332.
16. Food and Nutrition Board. Recommended Dietary Allowances. Washington, DC: National Academy Press; 1980.
17. Food and Nutrition Board. Recommended Dietary Allowances. Washington, DC: National Academy Press; 1989.
18. Levine M, Cantilena CC, Dhariwal KR. In situ kinetics and ascorbic add requirements. World Rev Nutr Diet. 1993;72:114-127.
19. Baker EM, Hodges RE, Hood J, et al. Metabolism of 14C-and 3H-labeled L-ascorbic acid in human scurvy. Am J Clin Nutr. 1971;24:444-454.
20. Washko PW, Weth RW, Dhariwal KR, et al. Ascorbic acid and dehydroascorbic acid analyses in biological samples. Anal Biochem. 1992;204:1-14.
21. Food and Nutrition Board. How Should the Recommended Dietary Allowances Be Revised? Washington, DC: National Academy Press; 1994.
22. US Department of Agriculture. USDA Nutrient Database for Standard Reference. Washington, DC: US Dept of Agriculture; 1998. Release 12.
23. Vanderslice JT, Higgs DJ. Vitamin C content of foods. Am J Clin Nutr. 1991;54(suppl):1323S-1327S.
24. Erdman JW, Klein BP. Harvesting, processing, and cooking influences on vitamin C in foods. In: Seib PA, Tolbert BM, eds. Ascorbic Acid: Chemistry, Metabolism, and Uses. Washington, DC: American Chemical Society; 1982:533-550.
25. Lachance P, Langseth L. The RDA concept. Nutr Rev. 1994;52:266-270.
26. Life Sciences Research Office. Third Report on Nutrition Monitoring in the United States. Washington, DC: US Government Printing Office; 1995:ES-14, 154, VA102, 222.
27. Simon JA, Schreiber GB, Crawford PB, et al. Dietary vitamin C and serum lipids in black and white girls. Epidemiology. 1993;4:537-542.
28. Basch CE, Zybert P, Shea S. 5-A-Day. Am J Public Health. 1994;84:814-818.
29. Koplan JP, Annest JL, Layde PM, et al. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health. 1986;76:287-289.
30. Patterson BH, Block G, Rosenberger WF, et al. Fruit and vegetables in the American diet. Am J Public Health. 1990;80:1443-1449.
31. Krebs-Smith SM. Progress in improving diet to reduce cancer risk. Cancer. 1998;83:1425-1432.
32. Block G, Sinha R, Gridley G. Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr. 1994;59(suppl):232S-239S.
33. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers. Proc Natl Acad Sci U S A. 1996;93:3704-3709.
34. Benet LZ, Kroetz DL, Sheiner LB. Pharmacokinetics. In: Herdman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman's The Pharmacologic Basis of Therapeutics. New York, NY: McGraw-Hill Book Co; 1996:3-27.
35. Graumlich JF, Ludden TM, Conry-Cantilena C, et al. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm Res. 1997;14:1133-1139.
36. Levine M, Rumsey S, Wang Y. Principles involved in formulating recommendations for vitamin C intake. Methods Enzymol. 1997;279:43-54.
37. Friedman GJ, Sherry S, Ralli E. The mechanism of excretion of vitamin C by the human kidney at low and normal plasma levels of ascorbic acid. J Clin Invest 1940;19:685-689.
38. Sullivan JF, Eisenstein AB. Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr. 1970;23:1339-1346.
39. Levine M, Dhariwal KR, Welch RW, et al. Determination of optimal vitamin C requirements in humans. Am J Clin Nutr. 1995;62(suppl):1347S-1356S.
40. Jaffe RM, Kasten B, Young DS, et al. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975; 83:824-826.
41. Gogel HK, Tandberg D, Strickland RG. Substances that interfere with guaiac card tests. Am J Emerg Med. 1989;7:474-480.
42. Nienhuis AW. Vitamin C and iron. N Engl J Med. 1981;304:170-171.
43. Young IS, Trouton TG, Tomey JJ, et al. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med. 1994;16:393-397.
44. Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Ann Intern Med. 1998; 129:932-939.
45. Cook JD, Watson SS, Simpson KM, et al. The effect of high ascorbic acid supplementation on body iron stores. Blood. 1984;64:721-726.
46. Stein HB, Hasan A, Fox IH. Ascorbic acid-induced uricosuria. Ann Intern Med. 1976;84:385-388.
47. Mitch WE, Johnson MW, Kirshenbaum JM, et al. Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981;29:318-321.
48. Sutton JL, Basu TK, Dickerson JW. Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr. 1983;37: 136-140.
49. Li MG, Madappally MM. Rapid enzymatic determination of urinary oxalate. Clin Chem. 1989;35: 2330-2333.
50. Wilson DM, Liedtke RR. Modified enzymebased colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference. Clin Chem. 1991;37:1229-1235.
51. Wandzilak TR, D'Andre SD, Davis PA, et al. Effect of high dose vitamin C on urinary oxalate levels. J Urol. 1994;151:834-837.
52. Tinchieri A, Mandressi A, Luongo P, et al. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol. 1991;67:230-236.
53. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing. J Urol. 1992;147:1215-1218.
54. Butz M, Kaiser M, Fitzner R. Enhancement of urinary oxalate excretion by vitamin C: fact or artifact? In: Ryall R, ed. Urolithiasis 2. New York, NY: Plenum Publishing Corp; 1994:133-135.
55. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria, and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest. 1998;28:695-700.
56. Auer BL, Auer D, Rodgers AL. The effect of ascorbic acid ingestion on the biochemical and physico-chemical risk factors associated with calcium oxalate kidney stone formation. Clin Chem Lab Med. 1998; 36:143-148.
57. Balcke P, Schmidt P, Zazgornik J, et al. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis. Ann Intern Med. 1984;101: 344-345.
58. Campbell GD Jr, Steinberg MH, Bower JD. Ascorbic acid-induced hemolysis in G-6-PD deficiency [letter]. Ann Intern Med. 1975;82:810.
59. Mehta JB, Singhal SB, Mehta BC. Ascorbic acid-induced haemolysis in C-6-PD deficiency [letter]. Lancet. 1990;336:944.
60. Rees DC, Kelsey H, Richards JD. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ. 1993; 306:841-842.
61. Rumsey SC, Levine M. Absorption, transport, and disposition of ascorbic acid in humans. J Nutr Biochem. 1998;9:116-130.
62. Levine M, Rumsey SC, Wang Y, et al. In situ kinetics. Methods Enzymol. 1997;281:425-437.
63. Washko PW, Wang Y, Levine M. Ascorbic acid recycling in human neutrophils. J Biol Chem. 1993; 268:15531-15535.
64. Wang Y, Russo TA, Kwon O, et al. Ascorbate recycling in human neutrophils. Proc Natl Acad Sci USA. 1997;94:13816-13819.
65. Rumsey SC, Kwon O, Xu GW, et al. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997;272:18982-18989.
66. Park JB, Levine M. Purification, cloning, and expression of dehydroascorbic acid reduction activity from human neutrophils. Biochem J. 1996;315:931-938.
67. Helser MA, Hotchkiss JH, Roe DA. Influence of fruit and vegetable juices on the endogenous formation of N-nitrosoproline and N-nitrosothiazolidine-4-carboxylic acid in humans on controlled diets. Carcinogenesis. 1992;13:2277-2280.
68. Yong LC, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer. Am J Epidemiol. 1997;146:231-243.
69. Byers T, Mouchawar J. Antioxidants and cancer prevention in 1997. In: Paoletti R, Sies H. Bug J, Grossi E, Poli A, eds. Vitamin C The State of the Art in Disease Prevention Sixty Years After the Nobel Prize. Milan, Italy: Springer; 1998:29-40.
70. Blot WJ, Li J-Y, Taylor PR, et al. Nutrition intervention trials in Linxian, China. J Natl Cancer Inst 1993; 85:1483-1492.
71. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. W Engl J Med. 1994;331:141-147.
72. Jacques PF, Taylor A, Hankinson SE, et al. Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr. 1997;66: 911-916.
73. Mares-Perlman JA. Contribution of epidemiol-ogy to understanding relations of diet to age-related cataract. Am J Clin Nutr. 1997;66:739-740.
74. Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol. 1988;106:337-340.
75. Robertson JM, Donner AP, Trevlthick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr. 1991;53(suppl):346S-351S.
76. Leske MC, Chylack LT, Wu S-Y. The lens opacities case/control study. Arch Ophthalmol. 1991;109: 244-251.
77. Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsularcataracts. Am J Epidemiol. 1991;133:541-553.
78. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration. Am J Epidemiol. 1988;128:700-710.
79. Vitale S, West S, Hallfrisch J, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology. 1993;4:195-203.
80. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women. BMJ. 1992;305:335-339.
81. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. Arch Ophthalmol. 1989;107:670-676, 1288.
82. Sahyoun NR, Jacques PF, Russell RM. Carolenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol. 1996;144:501-511.
83. Jha P, Flather M, Lonn E. The antioxidant vitamins and cardiovascular disease. Ann Intern Med. 1995; 123:860-872.
84. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons. Am J Clin Nub. 1996;64:190-196.
85. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3:194-202.
86. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA. 1994;272:1413-1420.
87. Riemersma RA, Wood DA, Macintyre CC, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.
88. Kushi LH, Fee RM, Sellers TA, et al. Intake of vitamins A, C, and E and postmenopausal breast cancer. Am J Epidemiol. 1996;144:165-174.
89. Simon JA, Hudes ES, Browner WS. Serum ascorbic acid and cardiovascular disease prevalence in US adults. Epidemiology. 1998;9:316-321.
90. Hltomi K, Tsukagoshi N. Role of ascorbic acid in modulation of gene expression. Subcell Biochem. 1996; 25:41-56.
91. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ. 1995; 310:1563-1566.
92. Nyyssonen K, Parviainen M, Salonen R, et al. Vitamin C deficiency and risk of myocardial infarction. BMJ. 1997;314:634-638.
93. Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr. 1980;33:2079-2087.
94. Singh RB, Chosh S, Niaz MA. et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol. 1995;76:1233-1238.
95. Schectman G. Estimating ascorbic acid requirements for cigarette smokers. Ann N Y Acad Sci. 1993; 686:335-345.
96. Vallance S. Changesin plasma and buffy layer vitamin C following surgery. Br J Surg. 1988;75:366-370.
97. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis. Free Radic Biol Med. 1996;20:139-143.
98. Allard JP, Aghdassi E, Chau J, et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS. 1998;12: 1653-1659.
99. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63:760-765.
100. Cross CE, Forte T, Stocker R, et al. Oxidative stress and abnormal cholesterol metabolism In patients with adult respiratory distress syndrome. J Lab Clin Med. 1990;115:396-404.
101. Scott P, Bruce C Schofield D. et al. Vitamin C status in patients with acute pancreatitis. Br J Surg. 1993;80:750-754.
102. Taylor TV, Rimmer S, Day B. et al. Ascorbic acid supplementation in the treatment of pressure-sores. Lancet. 1974;2:544-546.
103. Patterson JA, Bennett RG. Prevention and treatment of pressure sores. J Am Geriatr Soc. 1995;43: 919-927.
104. Hemila H. Vitamin C intake and susceptibility to the common cold. Br J Nutr. 1997;77:59-72.
105. Lind J. Treatise on the Scurvy. Paris, France: Chez Ganeau; 1756.
106. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes. J Am Diet Assoc. 1998;98:699-706.
107. Patterson BH, Krebs-Smith SM, Subar AF. Correction and revision of conclusions. N Engl J Med. 1997; 337:1846-1848.